Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease

Abstract Objective Neurocognitive complications in pediatric sickle cell disease (SCD)—even without overt stroke—are increasingly recognized, yet adolescents remain underrepresented in research. Adolescence is a critical window for brain maturation, particularly in regions supporting executive function, which are metabolically demanding and vulnerable to oxygen and nutrient deficits. This ongoing study aimed to characterize neurodevelopmental alterations in adolescents with SCD using comprehensive neurocognitive testing and multimodal MRI. Methods African American adolescents aged 12–17 years with severe SCD (HbSS or HbS/β⁰-thalassemia) and controls were enrolled. Stroke history was an exclusion criterion. Participants underwent a single visit including computerized neurocognitive assessment (NIH Toolbox), multimodal 3T MRI, and blood sampling. MRI protocols assessed cerebral perfusion (arterial spin labeling), brain structure (T1/T2-weighted imaging), metabolite levels (magnetic resonance spectroscopy), and white matter integrity (diffusion tensor imaging). Multivariable linear models included group and age as predictors. Results Sixteen participants (10 with SCD, 6 controls; mean age = 15.3 years; 53% female) were included. Adolescents with SCD showed significantly poorer executive function than controls (mean score: 89 vs. 109; p = 0.006). Cerebral perfusion was elevated in patients across all regions (p < 0.05). Significant group differences were observed in metabolite levels, including glutathione (difference (95% CI) = 0.07 [0.03, 0.11], p = 0.002), N-acetylaspartate (0.26 [0.04, 0.48], p = 0.025), and glycerophosphocholine (0.05 [0.01, 0.09], p = 0.015). Poorer executive function was associated with increased perfusion in the cerebrum (β = –1.60 [-2.61, -0.59], p = 0.005), cerebellum (β = -1.67 [-2.62, -0.73], p = 0.002), hippocampus (β = -0.93 [-1.75, -0.11], p = 0.029), and amygdala (β = -1.08 [-2.06, -0.10], p = 0.034). Reduced volumes of the hippocampus (β = -74.34 [-148.52, -0.17], p = 0.050), caudate (β = -68.12 [-131.54, -4.70], p = 0.037), and putamen (β = -105.99 [-193.15, -18.84], p = 0.021) were also significantly associated with executive dysfunction. Conclusion This study demonstrates that adolescents with SCD, even without stroke, show measurable disruptions in executive function that are potentially linked to altered perfusion, metabolite imbalance, and structural brain differences. These findings underscore the utility of multimodal neuroimaging in uncovering hidden neurodevelopmental vulnerabilities and support the need for targeted interventions during adolescence.

Authors

Institutions

Publication Details

Journal
Blood
Published
2025-11-03
DOI
https://doi.org/10.1182/blood-2025-2968
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease

Medhavi Honhar, Simon Chung, Trenesha L. Hill, Ellen van der Plas et al.
Blood
Hemoglobinopathies and Related Disorders
article

Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease

Medhavi Honhar, Simon Chung, Trenesha L. Hill, Ellen van der Plas, Shelley E. Crary, Timothy R. Koscik, Suzanne L. Saccente, Raghu Ramakrishnaiah, David K. Wilson, Bianca Mahomes
article en

Abstract

Abstract Objective Neurocognitive complications in pediatric sickle cell disease (SCD)—even without overt stroke—are increasingly recognized, yet adolescents remain underrepresented in research. Adolescence is a critical window for brain maturation, particularly in regions supporting executive function, which are metabolically demanding and vulnerable to oxygen and nutrient deficits. This ongoing study aimed to characterize neurodevelopmental alterations in adolescents with SCD using comprehensive neurocognitive testing and multimodal MRI. Methods African American adolescents aged 12–17 years with severe SCD (HbSS or HbS/β⁰-thalassemia) and controls were enrolled. Stroke history was an exclusion criterion. Participants underwent a single visit including computerized neurocognitive assessment (NIH Toolbox), multimodal 3T MRI, and blood sampling. MRI protocols assessed cerebral perfusion (arterial spin labeling), brain structure (T1/T2-weighted imaging), metabolite levels (magnetic resonance spectroscopy), and white matter integrity (diffusion tensor imaging). Multivariable linear models included group and age as predictors. Results Sixteen participants (10 with SCD, 6 controls; mean age = 15.3 years; 53% female) were included. Adolescents with SCD showed significantly poorer executive function than controls (mean score: 89 vs. 109; p = 0.006). Cerebral perfusion was elevated in patients across all regions (p < 0.05). Significant group differences were observed in metabolite levels, including glutathione (difference (95% CI) = 0.07 [0.03, 0.11], p = 0.002), N-acetylaspartate (0.26 [0.04, 0.48], p = 0.025), and glycerophosphocholine (0.05 [0.01, 0.09], p = 0.015). Poorer executive function was associated with increased perfusion in the cerebrum (β = –1.60 [-2.61, -0.59], p = 0.005), cerebellum (β = -1.67 [-2.62, -0.73], p = 0.002), hippocampus (β = -0.93 [-1.75, -0.11], p = 0.029), and amygdala (β = -1.08 [-2.06, -0.10], p = 0.034). Reduced volumes of the hippocampus (β = -74.34 [-148.52, -0.17], p = 0.050), caudate (β = -68.12 [-131.54, -4.70], p = 0.037), and putamen (β = -105.99 [-193.15, -18.84], p = 0.021) were also significantly associated with executive dysfunction. Conclusion This study demonstrates that adolescents with SCD, even without stroke, show measurable disruptions in executive function that are potentially linked to altered perfusion, metabolite imbalance, and structural brain differences. These findings underscore the utility of multimodal neuroimaging in uncovering hidden neurodevelopmental vulnerabilities and support the need for targeted interventions during adolescence.

BloodVol. 146(Supplement 1)
Arkansas Children's Hospital (US), Arkansas Children's Nutrition Center (US), University of Arkansas for Medical Sciences (US)
Openalex Percentile: Top 44%
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.